These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11167966)
41. Sucralfate suspension 1 g four times per day in the short-term treatment of active duodenal ulcer. Martin F Am J Med; 1989 Jun; 86(6A):104-7. PubMed ID: 2660550 [TBL] [Abstract][Full Text] [Related]
42. The association of ranitidine and sucralfate in the short-term treatment of duodenal ulcers, as compared to other forms of treatment. Magnanelli M; Belvisi A; Toninelli A; Matergi M; Camarri E Int J Tissue React; 1984; 6(2):189-93. PubMed ID: 6329980 [TBL] [Abstract][Full Text] [Related]
43. [Peristomal dermatitis: a common condition and a differential diagnostic challenge]. Fischer S; Kirchdorfer B; Ring J; Köhn FM MMW Fortschr Med; 2003 May; 145(21):43-6. PubMed ID: 12845868 [TBL] [Abstract][Full Text] [Related]
44. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study. Miller K Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707 [TBL] [Abstract][Full Text] [Related]
45. [Treatment of peptic ulcer with sucralfate]. Brailski Kh; Mendizova A; Matov V; Dimitrov B Klin Med (Mosk); 1991 Aug; 69(8):78-80. PubMed ID: 1791718 [TBL] [Abstract][Full Text] [Related]
46. Two daily doses of sucralfate or cimetidine in the healing of gastric ulcer. A comparative randomized study. Hjortrup A; Svendsen LB; Beck H; Hoffmann J; Schroeder M Am J Med; 1989 Jun; 86(6A):113-5. PubMed ID: 2660552 [TBL] [Abstract][Full Text] [Related]
47. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer. Winter TA; Louw JA; Marks IN; Jaskiewicz K; Lucke W; Callanan M Scand J Gastroenterol Suppl; 1995; 210():85-8. PubMed ID: 8578216 [TBL] [Abstract][Full Text] [Related]
48. Scalp necrotic wound and hyperinflammatory shock related to COVID-19: Topical sucralfate as a promising topical agent. Pourmoghaddas Z; Rastegarnasab F; Sabzghabaee AM; Abtahi-Naeini B Int Wound J; 2023 Apr; 20(4):1328-1330. PubMed ID: 36002913 [No Abstract] [Full Text] [Related]
50. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study. Alpsoy E; Er H; Durusoy C; Yilmaz E Arch Dermatol; 1999 May; 135(5):529-32. PubMed ID: 10328192 [TBL] [Abstract][Full Text] [Related]
51. Sucralfate cream in the management of moist desquamation during radiotherapy. Delaney G; Fisher R; Hook C; Barton M Australas Radiol; 1997 Aug; 41(3):270-5. PubMed ID: 9293679 [TBL] [Abstract][Full Text] [Related]
52. Comparison of two sucralfate dosages (2 g twice a day versus 1 g four times a day) in duodenal ulcer healing. Brandstaetter G; Kratochvil P Am J Med; 1985 Aug; 79(2C):36-8. PubMed ID: 3839972 [TBL] [Abstract][Full Text] [Related]
53. Study of peristomal skin disorders in patients with permanent stomas. Herlufsen P; Olsen AG; Carlsen B; Nybaek H; Karlsmark T; Laursen TN; Jemec GB Br J Nurs; 2006 Sep 14-27; 15(16):854-62. PubMed ID: 17108855 [TBL] [Abstract][Full Text] [Related]
54. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Kochhar R; Sriram PV; Sharma SC; Goel RC; Patel F Dig Dis Sci; 1999 May; 44(5):973-8. PubMed ID: 10235606 [TBL] [Abstract][Full Text] [Related]
55. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial. Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):628-35. PubMed ID: 11597802 [TBL] [Abstract][Full Text] [Related]
56. The impact of aluminium in acid-suppressing drugs on the immune response of BALB/c mice. Brunner R; Wallmann J; Szalai K; Karagiannis P; Kopp T; Scheiner O; Jensen-Jarolim E; Pali-Schöll I Clin Exp Allergy; 2007 Oct; 37(10):1566-73. PubMed ID: 17850381 [TBL] [Abstract][Full Text] [Related]
57. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 Mar; 27(3):194-209. PubMed ID: 6368184 [TBL] [Abstract][Full Text] [Related]
58. Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers. A double-blind, placebo-controlled trial. Van Deventer GM; Schneidman D; Walsh JH Am J Med; 1985 Aug; 79(2C):39-44. PubMed ID: 3898834 [TBL] [Abstract][Full Text] [Related]
59. The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin. Kamberi M; Nakashima H; Ogawa K; Oda N; Nakano S Br J Clin Pharmacol; 2000 Feb; 49(2):98-103. PubMed ID: 10671902 [TBL] [Abstract][Full Text] [Related]
60. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial. Nottage M; McLachlan SA; Brittain MA; Oza A; Hedley D; Feld R; Siu LL; Pond G; Moore MJ Support Care Cancer; 2003 Jan; 11(1):41-7. PubMed ID: 12527953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]